GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeoImmuneTech Inc (XKRX:950220) » Definitions » Policyholder Funds

NeoImmuneTech (XKRX:950220) Policyholder Funds


View and export this data going back to 2021. Start your Free Trial

What is NeoImmuneTech Policyholder Funds?

Policyholder Funds only applies to insurance companies.


NeoImmuneTech Business Description

Traded in Other Exchanges
N/A
Address
2400 Research Boulevard, Suite 250, Rockville, MD, USA, 20850
NeoImmuneTech Inc is a clinical-stage T cell-focused biotech company dedicated to the discovery and development of novel immuno-therapeutics. Its lead asset NT-I7 is the clinical stage IL-7, which enhances the body's immune function to address key resistance mechanisms in Immuno-Oncology and deadly infectious diseases.